Clinical Trials Browser

INDUSTRY × Recurrence × Rifampin × Clear all

NCT05602597 2024-03-06

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

Phase 1 Completed

Lymphoma, Recurrence

NCT05720767 2023-03-01

HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study

Phase 1 Completed

Lymphoma, Recurrence

NCT01969682 2014-05-26

A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

Phase 1 Withdrawn

Lymphoma, Non-Hodgkin, Neoplasms, Recurrence